Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Cancer Cell|February 14, 2023
Paradoxical cancer cell stimulation by IFNγ drives tumor hyperprogression upon checkpoint blockade immunotherapyStephane Champiat, Aurelien MarabelleImmunological Reviews|December 12, 2024
Fc Effector Function of Immune Checkpoint Blocking Antibodies in OncologyRomane Martineau, Sandrine Susini, Aurelien MarabelleNature Reviews. Clinical Oncology|October 10, 2019
Oncolysis without viruses - inducing systemic anticancer immune responses with local therapiesOliver Kepp, Aurelien Marabelle, Laurence Zitvogel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Active and passive immunotherapy for lymphoma: proving principles and improving resultsJoshua Brody, Holbrook Kohrt, Aurelien Marabelle, et al.British Journal of Cancer|November 11, 2018
PD-Loma: a cancer entity with a shared sensitivity to the PD-1/PD-L1 pathway blockadeLaure Hirsch, Laurence Zitvogel, Alexander Eggermont, et al.Current Opinion in Immunology|January 11, 2015
Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumorsCariad Chester, Aurelien Marabelle, Roch Houot, et al.Seminars in Radiation Oncology|December 8, 2014
Radiotherapy and toll-like receptor agonistsAurelien Marabelle, Alex Filatenkov, Idit Sagiv-Barfi, et al.Cancer Discovery|February 8, 2017
JAK Mutations as Escape Mechanisms to Anti-PD-1 TherapyAurelien Marabelle, Sandrine Aspeslagh, Sophie Postel-Vinay, et al.Nature Reviews. Clinical Oncology|May 19, 2021
Intratumoural administration and tumour tissue targeting of cancer immunotherapiesIgnacio Melero, Eduardo Castanon, Maite Alvarez, et al.Oncoimmunology|May 4, 2016
Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?Laura Rosa Brunet, Thorsten Hagemann, Gayab Andrew, et al.Pageof 7